Anika Therapeutics Stock Today
ANIK Stock | USD 25.90 0.11 0.43% |
Performance4 of 100
| Odds Of DistressLess than 6
|
Anika Therapeutics is selling for 25.90 as of the 25th of April 2024. This is a 0.43 percent increase since the beginning of the trading day. The stock's last reported lowest price was 25.72. Anika Therapeutics has only a 6 % chance of going through financial distress over the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Anika Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 26th of March 2024 and ending today, the 25th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 29th of April 1993 | Category Healthcare | Classification Health Care |
Anika Therapeutics, Inc., a joint preservation company, creates and delivers advancements in early intervention orthopedic care in the areas of osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies in the United States, Europe, and internationally. The company has 14.85 M outstanding shares of which 770.4 K shares are presently shorted by private and institutional investors with about 7.61 trading days to cover. More on Anika Therapeutics
Moving together with Anika Stock
0.8 | VKTX | Viking Therapeutics Potential Growth | PairCorr |
0.77 | ELEV | Elevation Oncology Earnings Call This Week | PairCorr |
Moving against Anika Stock
0.65 | GILD | Gilead Sciences Earnings Call Today | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 14th of May 2024
Anika Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Anika Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Anika Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO and President and Director | Charles Sherwood | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Medical Devices, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Average Analyst Recommendation Analysts covering Anika Therapeutics report their recommendations after researching Anika Therapeutics' financial statements, talking to executives and customers, or listening in on Anika Therapeutics' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Anika Therapeutics. The Anika consensus assessment is calculated by taking the average forecast from all of the analysts covering Anika Therapeutics. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial Strength Based on the key indicators related to Anika Therapeutics' liquidity, profitability, solvency, and operating efficiency, Anika Therapeutics may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of Anika Therapeutics is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Anika Therapeutics' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Anika Therapeutics' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Anika Therapeutics' financial leverage. It provides some insight into what part of Anika Therapeutics' total assets is financed by creditors.
|
Anika Therapeutics (ANIK) is traded on NASDAQ Exchange in USA. It is located in 32 Wiggins Avenue, Bedford, MA, United States, 01730 and employs 357 people. Anika Therapeutics is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 382.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Anika Therapeutics's market, we take the total number of its shares issued and multiply it by Anika Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Anika Therapeutics conducts business under Biotechnology sector and is part of Health Care industry. The entity has 14.85 M outstanding shares of which 770.4 K shares are presently shorted by private and institutional investors with about 7.61 trading days to cover.
Anika Therapeutics currently holds about 87.78 M in cash with (1.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.01.
Check Anika Therapeutics Probability Of Bankruptcy
Ownership AllocationAnika Therapeutics retains a total of 14.85 Million outstanding shares. The majority of Anika Therapeutics outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Anika Therapeutics to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Anika Therapeutics. Please pay attention to any change in the institutional holdings of Anika Therapeutics as this could imply that something significant has changed or is about to change at the company. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Anika Ownership Details
Anika Stock Price Odds Analysis
Proceeding from a normal probability distribution, the odds of Anika Therapeutics jumping above the current price in 90 days from now is about 16.11%. The Anika Therapeutics probability density function shows the probability of Anika Therapeutics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Anika Therapeutics has a beta of 0.9569. This suggests Anika Therapeutics market returns are very sensitive to returns on the market. As the market goes up or down, Anika Therapeutics is expected to follow. Additionally, anika Therapeutics has an alpha of 0.1501, implying that it can generate a 0.15 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
Based on a normal probability distribution, the odds of Anika Therapeutics to move above the current price in 90 days from now is about 16.11 (This Anika Therapeutics probability density function shows the probability of Anika Stock to fall within a particular range of prices over 90 days) .
Anika Stock Institutional Holders
Institutional Holdings refers to the ownership stake in Anika Therapeutics that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Anika Therapeutics' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Anika Therapeutics' value.Instituion | Recorded On | Shares | |
Geode Capital Management, Llc | 2023-12-31 | 318.9 K | |
State Street Corporation | 2023-12-31 | 309 K | |
Nuveen Asset Management, Llc | 2023-12-31 | 265.5 K | |
Arrowstreet Capital Limited Partnership | 2023-12-31 | 222.5 K | |
Invenomic Capital Management, Lp | 2023-12-31 | 210.3 K | |
Alta Fundamental Advisers Llc | 2023-12-31 | 192.5 K | |
D. E. Shaw & Co Lp | 2023-09-30 | 192.1 K | |
Goldman Sachs Group Inc | 2023-12-31 | 161.5 K | |
Northern Trust Corp | 2023-12-31 | 137.4 K | |
Trigran Investments Inc | 2023-12-31 | 2.1 M | |
Blackrock Inc | 2023-12-31 | 1.4 M |
Anika Therapeutics Historical Income Statement
Anika Therapeutics Income Statement is one of the three primary financial statements used for reporting Anika's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Anika Therapeutics revenue and expense. Anika Therapeutics Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Anika Therapeutics' Cost Of Revenue is quite stable compared to the past year. Total Operating Expenses is expected to rise to about 135 M this year, although the value of EBIT is projected to rise to (24.2 M). View More FundamentalsAnika Stock Against Markets
Picking the right benchmark for Anika Therapeutics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Anika Therapeutics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Anika Therapeutics is critical whether you are bullish or bearish towards Anika Therapeutics at a given time. Please also check how Anika Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Anika Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Idea Analyzer Now
Idea AnalyzerAnalyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |
All Next | Launch Module |
Anika Therapeutics Corporate Directors
Anika Therapeutics corporate directors refer to members of an Anika Therapeutics board of directors. The board of directors generally takes responsibility for the Anika Therapeutics' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Anika Therapeutics' board members must vote for the resolution. The Anika Therapeutics board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.Raymond Land | Independent Director | Profile | |
Susan Vogt | Independent Director | Profile | |
Joseph Bower | Lead Independent Director | Profile | |
Jeffrey Thompson | Independent Director | Profile |
How to buy Anika Stock?
Before investing in Anika Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Anika Therapeutics. To buy Anika Therapeutics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Anika Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Anika Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Anika Therapeutics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Anika Therapeutics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Anika Therapeutics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Anika Stock please use our How to Invest in Anika Therapeutics guide.
Already Invested in Anika Therapeutics?
The danger of trading Anika Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Anika Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Anika Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Anika Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Anika Therapeutics is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Anika Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Anika Therapeutics Stock. Highlighted below are key reports to facilitate an investment decision about Anika Therapeutics Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anika Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Anika Stock analysis
When running Anika Therapeutics' price analysis, check to measure Anika Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anika Therapeutics is operating at the current time. Most of Anika Therapeutics' value examination focuses on studying past and present price action to predict the probability of Anika Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anika Therapeutics' price. Additionally, you may evaluate how the addition of Anika Therapeutics to your portfolios can decrease your overall portfolio volatility.
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Global Correlations Find global opportunities by holding instruments from different markets | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Anika Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.51) | Earnings Share (5.64) | Revenue Per Share 11.372 | Quarterly Revenue Growth 0.085 | Return On Assets (0.02) |
The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.